SMYD5 and gastric cancer: Furthermore, inhibition of either SMYD5 or its substrate rpL40K22me3 has been shown to significantly reduce the metastasis of gastric cancer cells and increase sensitivity to PI3K-mTOR inhibitors in gastric cancer [8].